Donor-Reactive Regulatory T Cell Frequency Increases during Acute Cellular Rejection of Lung Allografts

Transplantation

Volumn 100, Issue 10, 2016, Pages 2090-2098

  Greenland, John R ^a,b   Wong, Charissa M ^b   Ahuja, Rahul ^a   Wang, Angelia S ^b   Uchida, Chiyo ^b   Golden, Jeffrey A ^b   Hays, Steven R ^b   Leard, Lorriana E ^b   Rajalingam, Raja ^b   Singer, Jonathan P ^b   Kukreja, Jasleen ^b   Wolters, Paul J ^b   Caughey, George H ^a,b,c   Tang, Qizhi ^b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; BRONCHOSCOPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; LUNG ALLOGRAFT; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGULATORY T LYMPHOCYTE; ACUTE DISEASE; ADVERSE EFFECTS; ALLOTRANSPLANTATION; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; MIDDLE AGED;

ACUTE DISEASE; AGED; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84963568352     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000001191     Document Type: Article

References (40)

1. Yusen RD, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report-2014; focus theme: retransplantation. J Heart Lung Transplant. 2014;33:1009-1024.
2. McManigle W, Pavlisko EN, Martinu T. Acute cellular and antibodymediated allograft rejection. Semin Respir Crit Care Med. 2013;34: 320-335.
3. Levine SM. A survey of clinical practice of lung transplantation in North America. Chest. 2004;125:1224-1238.
4. Tiriveedhi V, Takenaka M, Ramachandran S, et al. T regulatory cells play a significant role inmodulatingMHC class I antibody-induced obliterative airway disease. Am J Transplant. 2012;12:2663-2674.
5. Pilat N, Farkas AM, Mahr B, et al. T-regulatory cell treatment prevents chronic rejection of heart allografts in a murine mixed chimerism model. J Heart Lung Transplant. 2014;33:429-437.
6. Dodd-o JM, Lendermon EA, Miller HL, et al. CD154 blockade abrogates allospecific responses and enhances CD4(+) regulatory T-cells in mouse orthotopic lung transplant. Am J Transplant. 2011;11: 1815-1824.
7. Lee K, Nguyen V, Lee KM, et al. Attenuation of donor-reactive Tcells allows effective control of allograft rejection using regulatory T cell therapy. Am J Transplant. 2014;14:27-38.
8. Nakagiri T, Warnecke G, Avsar M, et al. Lung function early after lung transplantation is correlated with the frequency of regulatory T cells. Surg Today. 2012;42:250-258.
9. San Segundo D, Ballesteros MÁ, Naranjo S, et al. Increased numbers of circulating CD8 effector memory T cells before transplantation enhance the risk of acute rejection in lung transplant recipients. PLoS One. 2013; 8:e80601.
10. Greenland JR, Jewell NP, Gottschall M, et al. Bronchoalveolar lavage cell immunophenotyping facilitates diagnosis of lung allograft rejection. Am J Transplant. 2014;14:831-840.
11. Krustrup D, Madsen CB, IversenM, et al. The number of regulatory Tcells in transbronchial lung allograft biopsies is related to FoxP3mRNA levels in bronchoalveolar lavage fluid and to the degree of acute cellular rejection. Transpl Immunol. 2013;29:71-75.
12. Boer K, Caliskan K, Peeters AM, et al. Thymus-derived regulatory T cells infiltrate the cardiac allograft before rejection. Transplantation. 2015;99: 1839-1846.
13. Tang Q, Bluestone JA. Regulatory T-cell therapy in transplantation: moving to the clinic. Cold Spring Harb Perspect Med. 2013;3. pii: a015552.
14. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377-381.
15. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant. 2007;26:1229-1242.
16. Greenland JR, Jones KD, Hays SR, et al. Association of large-airway lymphocytic bronchitis with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2013;187:417-423.
17. PutnamAL, Safinia N,Medvec A, et al. Clinical grademanufacturing of human alloantigen-reactive regulatory Tcells for use in transplantation. Am J Transplant. 2013;13:3010-3020.
18. Noorchashm H, Lieu YK, Rostami SY, et al. A direct method for the calculation of alloreactive CD4+ T cell precursor frequency. Transplantation. 1999;67:1281-1284.
19. Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-ninth official adult heart transplant report-2012. J Heart Lung Transplant. 2012;31: 1073-1086.
20. Yusen RD, Christie JD, Edwards LB, et al. The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heartlung transplant report-2013; focus theme: age. J Heart Lung Transplant. 2013;32:965-978.
21. Greenland J, Wong C, Ahuja R, et al. Depletion of donor-reactive regulatory Tcells following induction with basiliximab. Am Thor Soc Int Conf Abstracts. 2015:A1444.
22. Suchin EJ, Langmuir PB, Palmer E, et al. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol. 2001;166:973-981.
23. Lin YJ, Hara H, Tai HC, et al. Suppressive efficacy and proliferative capacity of human regulatory T cells in allogeneic and xenogeneic responses. Transplantation. 2008;86:1452-1462.
24. Krystufkova E, Sekerkova A, Striz I, et al. Regulatory Tcells in kidney transplant recipients: the effect of induction immunosuppression therapy. Nephrol Dial Transplant. 2012;27:2576-2582.
25. Vondran FW, Timrott K, Tross J, et al. Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation. Transpl Int. 2010;23:514-523.
26. Bluestone JA, Liu W, Yabu JM, et al. The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. Am J Transplant. 2008;8:2086-2096.
27. Kamada N, Shinomiya T. Clonal deletion as the mechanism of abrogation of immunological memory following liver grafting in rats. Immunology. 1985;55:85-90.
28. Antczak DF, Howard JC. Analysis of lymphocytes reactive to histocompatibility antigens. III. Detection of inclusion among allo-reactive lymphocyte populations by specific depletion of reactive cells. Cell Immunol. 1979;46:119-126.
29. Poggio ED, Augustine JJ, Clemente M, et al. Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection. Transplantation. 2007;83:847-852.
30. Martinu T, Chen DF, Palmer SM. Acute rejection and humoral sensitization in lung transplant recipients. Proc Am Thorac Soc. 2009;6:54-65.
31. Hachem RR, Khalifah AP, ChakinalaMM, et al. The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation. 2005;80:1406-1413.
32. De Hoyos A, Chamberlain D, Schvartzman R, et al. Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation. Chest. 1993;103:1813-1818.
33. Pilewski J. Evaluation and treatment of acute lung transplant rejection. http://www.uptodate.com/. Updated November 7th, 2014. Accessed October 27th, 2015.
34. Valentine VG, Gupta MR, Weill D, et al. Single-institution study evaluating the utility of surveillance bronchoscopy after lung transplantation. J Heart Lung Transplant. 2009;28:14-20.
35. Akimova T, Beier UH,Wang L, et al. Helios expression is a marker of Tcell activation and proliferation. PLoS One. 2011;6:e24226.
36. Himmel ME, MacDonald KG, Garcia RV, et al. Helios+ and Helios? cells coexist within the natural FOXP3+ T regulatory cell subset in humans. J Immunol. 2013;190:2001-2008.
37. Kim HJ, Barnitz RA, Kreslavsky T, et al. Stable inhibitory activity of regulatory T cells requires the transcription factor Helios. Science. 2015;350: 334-339.
38. Veerapathran A, Pidala J, Beato F, et al. Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly. Blood. 2011;118: 5671-5680.
39. Bhorade SM, Husain AN, Liao C, et al. Interobserver variability in grading transbronchial lung biopsy specimens after lung transplantation. Chest. 2013;143:1717-1724.
40. Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med. 2005;353: 2342-2351.